Nanoparticles may allow more targeted brain tumor treatment

03/21/2012 | Engineer (U.K.), The

Researchers from the University of Texas Health Science Center used nanoparticles to deliver rhenium-186 directly to brain tumors. The method, which allowed for the agent to remain at the tumor site and limit radiation exposure in healthy tissue while delivering a high dose to the tumor, was successful in animal models, according to the study published in the journal Neuro-Oncology. Researchers hope to start a clinical trial by this summer.

View Full Article in:

Engineer (U.K.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR